"Designing Growth Strategies is in our DNA"

Dementia Care Products Market Size, Share, and Industry Analysis, By Type (Memory Aids/Daily Reminder Products, Bathroom Aids, Walking & Activity Products, Personal Safety Products, and Others), By Disease Type (Alzheimer's Induced Dementia, Vascular Dementia, Lewy Body Dementia, and Others), By End-user (Long-Term Care Centers, Home Care Settings, and Others), and Regional Forecast, 2025-2032

Region : Global | Report ID: FBI111651 | Status : Ongoing

 

KEY MARKET INSIGHTS

The global dementia care products market is witnessing significant growth due to their increasing adoption influenced by a high prevalence of the condition, especially in the low-and-middle-income countries, increased awareness about care products, supportive government policies, and technological advancements in care products.

  • For instance, as per data published by the World Health Organization (WHO) in March 2023, over 55.0 million people globally were living with dementia and 60.0% among them were from low-and middle-income countries. Such a high disease burden may spur the demand for care products, propelling the market growth.

Dementia Care Products Market Driver

Increasing Incidence of Dementia to Boost Market Growth

In recent years, there has been a considerable rise in the incidence of cognitive disorders and dementia influenced by the increasing aging population and the development of Alzheimer's disease. This is anticipated to boost the utilization of dementia care products among the global population, thereby driving market growth.

  • For instance, according to data published by The Lancet Public Health in February 2022, in 2019, an estimated 57.4 million people were living with dementia globally. The number is expected to increase to 152.8 million by 2050. This is projected to boost the demand for dementia care products, contributing to market growth.

Download Free sample to learn more about this report.

According to data published by The Lancet Public Health, the global prevalence of dementia by 2050 is expected to account for 152.8 million.

Dementia Care Products Market Restraint

Accessibility Issues and Low Healthcare Spending May Hamper the Market Growth

In some countries, underdeveloped distribution channels may lead to the limited availability of dementia care products. Furthermore, the limited healthcare spending may exacerbate the situation, preventing individuals from affording available products. Such a scenario is anticipated to hinder market expansion.

  • For instance, in December 2023, the World Health Organization (WHO) reported that despite having an 8.0% proportion of the global population, low-income countries accounted for only 0.24% of global health expenditure. This may limit the adoption of dementia care products in these regions, hindering market growth.

Dementia Care Products Market Opportunity

Advancements in Dementia Care Products May Spur Market Expansion

The integration of artificial intelligence, virtual reality, big data, and the Internet of Things (IoT) into dementia care products enhances their effectiveness. Moreover, wearable devices and monitoring systems can help track patient's activities and health conditions, thereby leading to better outcomes. This is expected to contribute significantly to market expansion in the near future.

  • For instance, according to innovations shared by the Alzheimer's Society in May 2023, companies such as Recreo VR are creating virtual reality experiences that help with reminiscence therapy. These experiences aim to improve the mental and social well-being of people with dementia. Such efforts are expected to create many opportunities for growth in the market.

Segmentation

By Type

By Disease Type

By End-user

By Geography

  • Memory Aids/Daily Reminder Products
  • Bathroom Aids
  • Walking & Activity Products
  • Personal Safety Products
  • Others
  • Alzheimer's Induced Dementia
  • Vascular Dementia
  • Lewy Body Dementia
  • Others
  • Long-Term Care Centers
  • Home Care Settings
  • Others

· North America (U.S. and Canada)

· Europe (U.K., Germany, France, Spain, Italy, Scandinavia, and the Rest of Europe)

· Asia Pacific (Japan, China, India, Australia, Southeast Asia, and the Rest of Asia Pacific)

· Latin America (Brazil, Mexico, and the Rest of Latin America)

· Middle East & Africa (South Africa, GCC, and Rest of the Middle East & Africa)

Key Insights

The report covers the following key insights:

  • Incidence of Key Diseases, By Key Countries/Region, 2023
  • Management of Dementia: An Overview
  • Technological Advancements in Dementia Care Products Market
  • Key Industry Developments (Mergers, Acquisitions, and Partnerships)
  • Impact of COVID-19 on the Market

Analysis by Type

Based on type, the market is segmented into memory aids/daily reminder products, bathroom aids, walking & activity products, personal safety products, and others.

The memory aids/daily reminder products segment is expected to hold a major share of the global market. Memory aids are crucial for helping individuals with dementia manage daily tasks and maintain a sense of routine, enhancing daily functioning and independence. This may spur the demand for these products, augmenting the segment growth over the forthcoming years.

  • For instance, as of 2025, Search Care Ltd. listed the five top-selling dementia care products, including Unforgettable 2-in-1 Calendar & Day Clock 7", a dementia clock that provides clear displays of time and date, reducing confusion and anxiety about daily schedules. These benefits associated with the product may increase their adoption rate, contributing to the segment growth.

Analysis by Disease Type

On the basis of disease type, the market is fragmented into Alzheimer's induced dementia, vascular dementia, lewy body dementia, and others.

The lewy body dementia segment is expected to hold a moderate share of the global market during the forecast period. The segment growth can be attributed to the high prevalence of this condition, leading to several complications and spurring the demand for the utilization of dementia care products, such as walking and activity products.

  • For instance, an article published by the National Library of Medicine in November 2021 stated that in the U.S., an estimated 1.4 million people have Lewy body dementia (LBD) currently, which is expected to boost the demand for dementia care products, propelling the segment growth.

Analysis by End-user

Based on end-user, the market is subdivided into long-term care centers, home care settings, and others.

The long-term care centers segment is projected to expand at a substantial CAGR during the projection period. The growth is mainly attributed to the increasing number of residents suffering from dementia in long-term care centers, which may spur the demand for care products in these settings.

  • For instance, according to data published by Arjo in June 2024, it was estimated that between 60.0% and 80.0% of residents in long-term care facilities had dementia or other cognitive impairments. Such a scenario is expected to boost the utilization of dementia care products in these settings, driving the segment growth.

Regional Analysis

To gain extensive insights into the market, Download for Customization

Based on region, the market has been studied across North America, Asia Pacific, Europe, Latin America, and the Middle East & Africa.

North America accounted for the largest share of the global dementia care products market in 2023. The regional growth is attributed to the high burden of Alzheimer's disease (AD) in the U.S., which is the leading cause of dementia. This is expected to spur the adoption of dementia care products, driving the regional market growth.

  • For instance, according to an article published by NCBI on April 2023, an estimated 6.7 million U.S. individuals aged 65 and older were currently living with Alzheimer's disease (AD), and this number is projected to reach 13.8 million by 2060. Such a growing burden of Alzheimer's disease, leading to an increase in dementia patients, may boost the regional market growth.

Europe is the second-largest market based on the demand for dementia care products. The growth is driven by several factors such as the presence of prominent players, high product accessibility, and healthcare expenditures.

The Asia Pacific market is expected to grow at the highest CAGR during the forecast period. The region's growth can be attributed to the high burden of aged individuals who are prone to be affected by dementia. Such a scenario may surge the adoption of care products for the management of these conditions, which is anticipated to boost the regional growth.

  • For instance, according to data published by the NCBI, in July 2023, in India, the prevalence of dementia is estimated to be 7.4% for adults aged 60 and older. In such cases, the large base of the geriatric population may spur the demand for dementia care products, fueling the region's growth.

Key Players Covered

The global dementia care products market is fragmented, with many companies offering various care products.

The report includes the profiles of the following key players:

  • IN. (India)
  • Parentgiving (U.S.)
  • Find Signage Ltd (U.K.)
  • Golden Care Products (U.K.)
  • Buddi Limited (U.K.)
  • ElderEase (India)
  • MindCare (U.S.)
  • Eugeria (U.S.)
  • Arjo (Sweden)

Key Industry Developments

  • In June 2024, Arjo received DSDC certification for the Carino shower chair and the Carevo shower trolley for dementia patients.
  • In May 2023, the Alzheimer's Society announced its support for Pobroll, a totally waterproofed luxury bed-bathing wrap, to streamline its manufacturing process and launch this product, making it available in the hands of dementia patients.


  • Ongoing
  • 2024
  • 2019-2023
Download Free Sample

    man icon
    Mail icon
Growth Advisory Services
    How can we help you uncover new opportunities and scale faster?
Healthcare Clients
3M
Toshiba
Fresenius
Johnson
Siemens
Abbot
Allergan
American Medical Association
Becton, Dickinson and Company
Bristol-Myers Squibb Company
Henry Schein
Mckesson
Mindray
National Institutes of Health (NIH)
Nihon Kohden
Olympus
Quest Diagnostics
Sanofi
Smith & Nephew
Straumann